-
Alexandria Real Estate Equities reported third quarter 2026 revenue of US$671.18 million and a net loss of US$637.69 million, driven in large part by US$637.90 million of real estate impairments, alongside lower sales and no share repurchases under its existing buyback plan.
-
The business paired this impairment heavy quarter with strong leasing of more than 1.2 million square feet and a US$475 million Campus Point joint venture. Together, these developments point to management leaning on its Megacampus model and external capital partnerships to support liquidity in an oversupplied biotech market.
-
We will look at how Alexandria Real Estate Equities' Megacampus investment narrative is affected by heavy impairments alongside the Campus Point joint venture.
Scan Alexandria Real Estate Equities alongside a hand-picked 32 resilient stocks with low risk scores that may hold up better when real estate impairments and leasing risk are front and center.
Alexandria Real Estate Equities Investment Narrative Recap
To own Alexandria Real Estate Equities, you need to believe its Megacampus focused life science model and long leases can offset a tougher biotech leasing backdrop and impairments. The latest quarter keeps that tension front and center. Heavy real estate write downs and a larger loss sit opposite solid leasing volume and long lease terms.
The near term swing factor is occupancy and rent on upcoming expiries, especially with management already flagging pressure in early 2027. The biggest risk is that elevated vacancies and further impairment driven asset sales keep net operating income under strain, even as the firm trims its development pipeline and recycles capital.
The Campus Point joint venture with KKR, which brought in US$475 million for a 49% stake while Alexandria Real Estate Equities kept operational control, is the announcement that ties most directly to this earnings story. It sits inside the broader US$2.9 billion capital recycling effort that aims to fund projects without leaning harder on debt.
For you as a shareholder, this matters because the same quarter that recorded US$637.90 million of impairments also showed Alexandria using external partners to share project risk, support liquidity, and still lean on its Megacampus approach. Execution on similar joint ventures now intersects directly with the key catalyst of managing leverage and occupancy.
Alexandria Real Estate Equities' narrative projects US$2.5b revenue and US$278.8 million earnings by 2029. This assumes revenue declines at 4.3% per year and earnings rise by about US$1.3b, moving from the current loss of US$1.0b to the forecast profit of US$278.8 million.
Uncover how Alexandria Real Estate Equities' fair value indicates a 32% potential upside to its current price that may be temporary.
Exploring Other Perspectives
For Alexandria Real Estate Equities, the most optimistic analysts were leaning hard on the Campus Point style joint venture playbook. They were penciling in roughly US$2.7b of revenue and about US$303.0 million of earnings by 2029. You can read that as a far more upbeat view on leasing and capital recycling that may shift after this impairment heavy quarter.
Explore 5 other Alexandria Real Estate Equities fair value estimates , including one that suggests the potential for as much as 120% upside from the current price.
Decide For Yourself
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
-
A great starting point for your Alexandria Real Estate Equities research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
-
See our latest analysis for Alexandria Real Estate Equities. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Alexandria Real Estate Equities' overall financial health at a glance.
Looking For More Investment Ideas Beyond Alexandria Real Estate Equities?
If the Alexandria Real Estate Equities story has you reassessing risk, income, and balance sheet strength, it can help to line it up against a broader watchlist built with a consistent process.
-
Put resilience first by checking companies that screen for lower risk profiles through the 32 resilient stocks with low risk scores .
-
If value is your priority, scan for companies combining quality fundamentals with room for re rating through the 26 high quality undervalued stocks .
-
For investors who care most about income, review potential high yield payers using the 6 dividend fortresses .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ARE .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
